Period problems: Disorders of menstruation in adolescents

Archives of Disease in Childhood

Volumn 97, Issue 6, 2012, Pages 554-560

  Peacock, A ^a   Alvi, N S ^a   Mushtaq, Talat ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

AMENORRHEA; BODY MASS; BONE DENSITY; CELL PROLIFERATION; CHILDHOOD OBESITY; CORPUS LUTEUM; DYSMENORRHEA; ENDOMETRIUM; EXERCISE INDUCED AMENORRHEA; FEMALE; FOLLICULAR PHASE; HUMAN; HYPERANDROGENISM; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LOW BIRTH WEIGHT; LUTEAL PHASE; MENARCHE; MENORRHAGIA; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; OVARY POLYCYSTIC DISEASE; OVULATION; POSTNATAL GROWTH; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EATING DISORDERS; FEMALE; HUMANS; MENARCHE; MENSTRUAL CYCLE; MENSTRUATION DISTURBANCES; POLYCYSTIC OVARY SYNDROME;

EID: 84861480606     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.160853     Document Type: Review

References (80)

1. Balen AH, Fleming C, Robinson A. Health needs of adolescents in secondary gynaecological care: results of a questionnaire survey and a review of current issues. Hum Fertil (Camb) 2002;5:127-32.
2. Whincup PH, Gilg JA, Odoki K, et al. Age of menarche in contemporary British teenagers: survey of girls born between 1982 and 1986. BMJ 2001;322:1095-6. (Pubitemid 32411182)
3. Kaltiala-Heino R, Kosunen E, Rimpelä M. Pubertal timing, sexual behaviour and self-reported depression in middle adolescence. J Adolesc 2003;26:531-45. (Pubitemid 37321585)
4. Maskarinec G, Zhang Y, Takata Y, et al. Trends of breast cancer incidence and risk factor prevalence over 25 years. Breast Cancer Res Treat 2006;98:45-55. (Pubitemid 44050779)
5. Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 1997;99:505-12.
6. Chumlea WC, Schubert CM, Roche AF, et al. Age at menarche and racial comparisons in US girls. Pediatrics 2003;111:110-3. (Pubitemid 36071039)
7. Frisch RE, Revelle R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science 1970;169:397-9.
8. Frisch RE. Body fat, menarche, fitness and fertility. Hum Reprod 1987;2:521-33.
9. Garn SM, LaVelle M. Reproductive histories of low weight girls and women. Am J Clin Nutr 1983;37:862-6. (Pubitemid 13094872)
10. Lassek WD, Gaulin SJ. Brief communication: menarche is related to fat distribution. Am J Phys Anthropol 2007;133:1147-51. (Pubitemid 47173553)
11. Laitinen J, Power C, Järvelin MR. Family social class, maternal body mass index, childhood body mass index, and age at menarche as predictors of adult obesity. Am J Clin Nutr 2001;74:287-94. (Pubitemid 32802012)
12. Sloboda DM, Hart R, Doherty DA, et al. Age at menarche: influences of prenatal and postnatal growth. J Clin Endocrinol Metab 2007;92:46-50. (Pubitemid 46067507)
13. Hillard P. Menstruation in adolescents, what's normal, what's not. Ann N Y Acad Sci 2008;1135:29-35. (Pubitemid 351863669)
14. World Health Organization. Multicenter study on menstrual and ovulatory patterns in adolescent girls. II. Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles. World Health Organization Task Force on Adolescent Reproductive Health. J Adolesc Health Care 1986;7:236-44.
15. Murram D, Dewhurst J, Grant DB. Premature menarche: a follow-up study. Arch Dis Child 1983;58:142-3. (Pubitemid 13152867)
16. Pinto SM, Garden AS. Prepubertal menarche: a defined clinical entity. Am J Obstet Gynecol 2006;195:327-9. (Pubitemid 43927491)
17. Paediatric and Adolescent Gynaecology. A multidisciplinary approach. Balen AH, ed. Cambridge: Cambridge University Press, 2004:334-59.
18. Mushtaq T, Wales JK. Diagnosis, investigation and treatment of delayed puberty in children. Paediatr Child Health 2007;17:343-78.
19. Laufer MR, Floor AE, Parsons KE, et al. Hormone testing in women with adultonset amenorrhea. Gynecol Obstet Invest 1995;40:200-3.
20. Golden NH, Jacobson MS, Schebendach J, et al. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 1997;151:16-21. (Pubitemid 27036513)
21. Misra M, Miller KK, Almazan C, et al. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab 2004;89:3486-95. (Pubitemid 38951925)
22. Castellano JM, Roa J, Luque RM, et al. KiSS-1/kisspeptins and the metabolic control of reproduction: physiologic roles and putative physiopathological implications. Peptides 2009;30:139-45.
23. Karen K, Miller K, Grinspoon JC, et al. Medical findings in outpatients with anorexia nervosa. Arch Intern Med 2005;165 :561-6. (Pubitemid 40344389)
24. Miller KK, Lee EE, Lawson EA, et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 2006;91:2931-7. (Pubitemid 44271738)
25. Hartman D, Crisp A, Rooney B, et al. Bone density of women who have recovered from anorexia nervosa. Int J Eat Disord 2000;28:107-12. (Pubitemid 30322170)
26. Strokosch GR, Friedman AJ, Wu SC, et al. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J Adolesc Health 2006;39:819-27. (Pubitemid 44751505)
27. Stager JM, Robertshaw D, Miescher E. Delayed menarche in swimmers in relation to age at onset of training and athletic performance. Med Sci Sports Exerc 1984;16:550-5. (Pubitemid 15178315)
28. Vadocz EA, Siegel SR, Malina RM. Age at menarche in competitive figure skaters: variation by competency and discipline. J Sports Sci 2002;20:93-100
29. Nichols JF, Rauh MJ, Lawson MJ, et al. Prevalence of the female athlete triad syndrome among high school athletes. Arch Pediatr Adolesc Med 2006;160:137-42.
30. Torstveit MK, Sundgot-Borgen J. Participation in leanness sports but not training volume is associated with menstrual dysfunction: a national survey of 1276 elite athletes and controls. Br J Sports Med 2005;39:141-7. (Pubitemid 40314908)
31. Nattiv A, Loucks AB, Manore MM, et al. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 2007;39:1867-82.
32. Hallberg L, Högdahl AM, Nilsson L, et al. Menstrual blood loss-a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320-51.
33. ACOG Committee Opinion No. 349. November 2006. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol 2006;108:1323-8.
34. Wyatt KM, Dimmock PW, Walker TJ, et al. Determination of total menstrual blood loss. Fertil Steril 2001;76:125-31. (Pubitemid 32600969)
35. Jayasinghe Y, Moore P, Donath S, et al. Bleeding disorders in teenagers presenting with menorrhagia. Aust N Z J Obstet Gynaecol 2005;45:439-43. (Pubitemid 41830370)
36. Philipp CS, Faiz A, Dowling N, et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 2005;105:61-6. (Pubitemid 40189912)
37. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;4:CD000249.
38. Oehler MK, Rees MC. Menorrhagia: an update. Acta Obstet Gynecol Scand 2003;82:405-22.
39. Hurskainen R, Grenman S, Komi I, et al. Diagnosis and treatment of menorrhagia. Acta Obstet Gynecol Scand 2007;86:749-57. (Pubitemid 46801790)
40. Archer DF. Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives. Contraception 2006;74:359-66. (Pubitemid 44527903)
41. Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2008;23:CD001016.
42. Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics 1981;68:661-4.
43. Hillen TI, Grbavac SL, Johnston PJ, et al. Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health 1999;25:40-5. (Pubitemid 29316270)
44. Harel Z. Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies. Expert Opin Pharmacother 2008;9:2661-72.
45. Marjoribanks J, Proctor M, Farquhar C, et al. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2010;1:CD001751.
46. Sulak PJ, Cressman BE, Waldrop E, et al. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 1997;89:179-83. (Pubitemid 27057203)
47. Walling MK, O'Hara MW, Reiter RC, et al. Abuse history and chronic pain in women: II. A multivariate analysis of abuse and psychological morbidity. Obstet Gynecol 1994;84:200-6. (Pubitemid 24234826)
48. Creatsas G, Deligeoroglou E. Polycystic ovarian syndrome in adolescents. Curr Opin Obstet Gynecol 2007;19:420-6. (Pubitemid 47462233)
49. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
50. Moran A, Jacobs DR Jr, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999;48:2039-44. (Pubitemid 29458369)
51. Ankarberg C, Norjavaara E. Diurnal rhythm of testosterone secretion before and throughout puberty in healthy girls: correlation with 17beta-estradiol and dehydroepiandrosterone sulfate. J Clin Endocrinol Metab 1999;84:975-84. (Pubitemid 29138229)
52. Hashemipour M, Faghihimani S, Zolfaghary B, et al. Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran. Horm Res 2004;62:278-82. (Pubitemid 40069626)
53. de Zegher F, Ibáñez L. Early origins of polycystic ovary syndrome: hypotheses may change without notice. J Clin Endocrinol Metab 2009;94:3682-5.
54. Rodin DA, Bano G, Bland JM, et al. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin Endocrinol (Oxf) 1998;49:91-9. (Pubitemid 28338048)
55. Franks S, McCarthy MI, Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl 2006;29:278-85; discussion 286-90.
56. Nestler JE. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin Reprod Endocrinol 1997;15:111-22. (Pubitemid 27217222)
57. Blank SK, Helm KD, McCartney CR, et al. Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci 2008;1135:76-84. (Pubitemid 351862121)
58. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-7.
59. Biro FM, Emans SJ. Whither PCOS? The challenges of establishing hyperandrogenism in adolescent girls. J Adolesc Health 2008;43:103-5. (Pubitemid 351970703)
60. Diamanti-Kandarakis E. PCOS in adolescents. Best Pract Res Clin Obstet Gynaecol 2010;24:173-83.
61. Nestler JE, Powers LP, Matt DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991;72:83-9. (Pubitemid 21921660)
62. Zhou R, Bird IM, Dumesic DA, et al. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:6630-7. (Pubitemid 41759326)
63. Hickey M, Sloboda DM, Atkinson HC, et al. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab 2009;94:3714-20.
64. Ibáñez L, Potau N, Francois I, et al. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998;83:3558-62. (Pubitemid 28500889)
65. Ibañez L, Potau N, Virdis R, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993;76:1599-603. (Pubitemid 23164385)
66. Ibáñez L, Ong K, de Zegher F, et al. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clin Endocrinol (Oxf) 2003;58:372-9. (Pubitemid 36308127)
67. Meas T, Chevenne D, Thibaud E, et al. Endocrine consequences of premature pubarche in post-pubertal Caucasian girls. Clin Endocrinol (Oxf) 2002;57:101-6. (Pubitemid 34785890)
68. Cresswell JL, Barker DJ, Osmond C, et al. Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 1997;350:1131-5. (Pubitemid 27454005)
69. Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237-45. (Pubitemid 44833391)
70. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006;91:492-7. (Pubitemid 43236914)
71. Tang T, Lord JM, Norman RJ, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2010;1:CD003053.
72. Salley KE, Wickham EP, Cheang KI, et al. Glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007;92:4546-56. (Pubitemid 350223423)
73. Mastorakos G, Koliopoulos C, Creatsas G. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril 2002;77:919-27. (Pubitemid 34497157)
74. Diamanti-Kandarakis E, Baillargeon JP, Iuorno MJ, et al. A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. J Clin Endocrinol Metab 2003;88:1927-32. (Pubitemid 36549858)
75. Baillargeon JP, McClish DK, Essah PA, et al. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a metaanalysis. J Clin Endocrinol Metab 2005;90:3863-70. (Pubitemid 41058144)
76. Barth JH, Cherry CA, Wojnarowska F, et al. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study. Clin Endocrinol (Oxf) 1991;35:5-10.
77. Buggs C, Rosenfield RL. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am 2005;34:677-705. (Pubitemid 41112093)
78. Palep-Singh M, Mook K, Barth J, et al. An observational study of Yasmin in the management of women with polycystic ovarian syndrome. J Fam Plan Reprod Health Care 2004;30:163-5. (Pubitemid 38886306)
79. Ibáñez L, Valls C, Marcos MV, et al. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab 2004;89:4331-7. (Pubitemid 39244434)
80. Harwood K, Vuguin P, DiMartino-Nardi J. Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth. Horm Res 2007;68:209-17. (Pubitemid 47525222)